BioArctic AB (publ)
BRCTFOTCHealthcare● Active
$35.00
+$0.00(+0.00%)
Market Cap$3.1B
P/E Ratio—
52W High$38.75
52W Low$18.74
BioArctic AB (publ) (BRCTF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BRCTF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.99B | $0.26B | $0.62B | $0.23B | $0.02B |
| Cost of Revenue | $0.06B | $0.03B | $0.09B | $0.07B | $0.06B |
| Gross Profit | $1.94B | $0.23B | $0.53B | $0.15B | ($0.03B) |
| Gross Margin %(computed) | 97.04% | 89.51% | 85.45% | 67.44% | -137.91% |
| Operating Expenses | |||||
| R&D Expenses | $0.38B | $0.31B | $0.00B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.09B | $0.13B | $0.00B | $0.02B |
| Total Operating Expenses | $0.57B | $0.46B | $0.27B | $0.16B | $0.11B |
| Operating Income | $1.36B | ($0.23B) | $0.25B | ($0.02B) | ($0.14B) |
| Operating Margin %(computed) | 68.44% | -88.79% | 41.01% | -7.64% | -603.66% |
| Interest Income | $0.03B | $0.04B | $0.03B | $0.00B | $0.00B |
| Interest Expense | $0.04B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $1.25B | ($0.19B) | $0.28B | ($0.01B) | ($0.14B) |
| Income Tax Expense | $0.23B | ($0.01B) | $0.05B | $0.00B | ($0.02B) |
| Net Income | $1.02B | ($0.18B) | $0.23B | ($0.01B) | ($0.12B) |
| Net Margin %(computed) | 51.14% | -68.81% | 37.22% | -4.90% | -517.54% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $11.52 | $-2.00 | $2.59 | $-0.13 | $-1.36 |
| Wtd Avg Shares | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B |
| EBITDA | $1.38B | ($0.21B) | $0.30B | $0.00B | ($0.13B) |
| EBITDA Margin %(computed) | 69.08% | -82.06% | 47.93% | 1.76% | -546.82% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · SEK · B
Explore more BioArctic AB (publ) data
About BioArctic AB (publ) (BRCTF) Income Statement
BioArctic AB (publ) (BRCTF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BRCTF reported revenue of $1.99B, gross profit of $1.94B (gross margin 97.04%), and net income of $1.02B — a net profit margin of 51.14%.
Frequently asked questions
BRCTF · 4 questionsBioArctic AB (publ) (BRCTF) reported revenue of $1.99B for 2025, up 674.9% year-over-year.
BRCTF revenueBRCTF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08